These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 30642654)
1. Protein Kinase A as a Promising Target for Heart Failure Drug Development. Saad NS; Elnakish MT; Ahmed AAE; Janssen PML Arch Med Res; 2018 Nov; 49(8):530-537. PubMed ID: 30642654 [TBL] [Abstract][Full Text] [Related]
2. Ca2+/calmodulin-dependent protein kinase II and protein kinase A differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathology. Fischer TH; Herting J; Tirilomis T; Renner A; Neef S; Toischer K; Ellenberger D; Förster A; Schmitto JD; Gummert J; Schöndube FA; Hasenfuss G; Maier LS; Sossalla S Circulation; 2013 Aug; 128(9):970-81. PubMed ID: 23877259 [TBL] [Abstract][Full Text] [Related]
3. A-kinase anchoring protein targeting of protein kinase A in the heart. Ruehr ML; Russell MA; Bond M J Mol Cell Cardiol; 2004 Sep; 37(3):653-65. PubMed ID: 15350838 [TBL] [Abstract][Full Text] [Related]
4. Physiological and pathological roles of protein kinase A in the heart. Liu Y; Chen J; Fontes SK; Bautista EN; Cheng Z Cardiovasc Res; 2022 Jan; 118(2):386-398. PubMed ID: 33483740 [TBL] [Abstract][Full Text] [Related]
5. Genetic inhibition of PKA phosphorylation of RyR2 prevents dystrophic cardiomyopathy. Sarma S; Li N; van Oort RJ; Reynolds C; Skapura DG; Wehrens XH Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13165-70. PubMed ID: 20615971 [TBL] [Abstract][Full Text] [Related]
6. Assessment of PKA and PKC inhibitors on force and kinetics of non-failing and failing human myocardium. Saad NS; Elnakish MT; Brundage EA; Biesiadecki BJ; Kilic A; Ahmed AAE; Mohler PJ; Janssen PML Life Sci; 2018 Dec; 215():119-127. PubMed ID: 30399377 [TBL] [Abstract][Full Text] [Related]
7. Cardiotoxic and cardioprotective features of chronic β-adrenergic signaling. Zhang X; Szeto C; Gao E; Tang M; Jin J; Fu Q; Makarewich C; Ai X; Li Y; Tang A; Wang J; Gao H; Wang F; Ge XJ; Kunapuli SP; Zhou L; Zeng C; Xiang KY; Chen X Circ Res; 2013 Feb; 112(3):498-509. PubMed ID: 23104882 [TBL] [Abstract][Full Text] [Related]
8. Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol. Reiken S; Gaburjakova M; Guatimosim S; Gomez AM; D'Armiento J; Burkhoff D; Wang J; Vassort G; Lederer WJ; Marks AR J Biol Chem; 2003 Jan; 278(1):444-53. PubMed ID: 12401811 [TBL] [Abstract][Full Text] [Related]
9. PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle: defective regulation in heart failure. Reiken S; Lacampagne A; Zhou H; Kherani A; Lehnart SE; Ward C; Huang F; Gaburjakova M; Gaburjakova J; Rosemblit N; Warren MS; He KL; Yi GH; Wang J; Burkhoff D; Vassort G; Marks AR J Cell Biol; 2003 Mar; 160(6):919-28. PubMed ID: 12629052 [TBL] [Abstract][Full Text] [Related]
11. Human heart failure is accompanied by altered protein kinase A subunit expression and post-translational state. Han YS; Arroyo J; Ogut O Arch Biochem Biophys; 2013 Oct; 538(1):25-33. PubMed ID: 23942052 [TBL] [Abstract][Full Text] [Related]
12. Increased response to β₂-adrenoreceptor stimulation augments inhibition of IKr in heart failure ventricular myocytes. Wang H; Chen Y; Zhu H; Wang S; Zhang X; Xu D; Cao K; Zou J PLoS One; 2012; 7(9):e46186. PubMed ID: 23029432 [TBL] [Abstract][Full Text] [Related]
13. Modulation of atrial contraction by PKA and PKC during the compensated phase of eccentric cardiac hypertrophy. Haddad GE; Coleman BR; Zhao A; Blackwell KN Basic Res Cardiol; 2004 Sep; 99(5):317-27. PubMed ID: 15309409 [TBL] [Abstract][Full Text] [Related]
14. Molecule specific effects of PKA-mediated phosphorylation on rat isolated heart and cardiac myofibrillar function. Hanft LM; Cornell TD; McDonald CA; Rovetto MJ; Emter CA; McDonald KS Arch Biochem Biophys; 2016 Jul; 601():22-31. PubMed ID: 26854722 [TBL] [Abstract][Full Text] [Related]
16. The influence of PKA treatment on the Ca2+ activation of force generation by trout cardiac muscle. Gillis TE; Klaiman JM J Exp Biol; 2011 Jun; 214(Pt 12):1989-96. PubMed ID: 21613514 [TBL] [Abstract][Full Text] [Related]
17. Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure. Gesmundo I; Miragoli M; Carullo P; Trovato L; Larcher V; Di Pasquale E; Brancaccio M; Mazzola M; Villanova T; Sorge M; Taliano M; Gallo MP; Alloatti G; Penna C; Hare JM; Ghigo E; Schally AV; Condorelli G; Granata R Proc Natl Acad Sci U S A; 2017 Nov; 114(45):12033-12038. PubMed ID: 29078377 [TBL] [Abstract][Full Text] [Related]
18. Protein kinase C and cardiac dysfunction: a review. Singh RM; Cummings E; Pantos C; Singh J Heart Fail Rev; 2017 Nov; 22(6):843-859. PubMed ID: 28702857 [TBL] [Abstract][Full Text] [Related]
19. AKAP12 Signaling Complex: Impacts of Compartmentalizing cAMP-Dependent Signaling Pathways in the Heart and Various Signaling Systems. Qasim H; McConnell BK J Am Heart Assoc; 2020 Jul; 9(13):e016615. PubMed ID: 32573313 [TBL] [Abstract][Full Text] [Related]
20. Abnormal Ca2+ release, but normal ryanodine receptors, in canine and human heart failure. Jiang MT; Lokuta AJ; Farrell EF; Wolff MR; Haworth RA; Valdivia HH Circ Res; 2002 Nov; 91(11):1015-22. PubMed ID: 12456487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]